Home/Healthcare/Surgery/Gynecomastia Procedures Market

Gynecomastia Procedures Market - Strategic Insights and Forecasts (2026-2031)

Gynecomastia procedures market assessment focusing on treatment trends, patient demand, and surgical advancements.

$3,950
Single User License
Report OverviewSegmentationTable of ContentsCustomize Report

Request Customization

Tell us your specific requirements and we will customize this report for you.

📞

Your data is secure. We do not share information with any third party.

Gynecomastia Procedures Market Report

Report IDKSI061615893
PublishedApr 2026
Pages145
FormatPDF, Excel, PPT, Dashboard

Need Assistance?

Our research team is available to answer your questions.

Contact Us
Frequently Asked Questions

The Gynecomastia Procedures market is forecast to expand at a robust CAGR of 10.1%, increasing from USD 0.87 billion in 2026 to an estimated USD 1.41 billion by 2031. This growth is primarily driven by the long-term clinical prevalence of hormonal imbalances and the rising incidence of medication-induced breast tissue enlargement, positioning these procedures as corrective necessities rather than purely elective aesthetics.

Cosmetic surgical centers currently represent the largest end-user segment for gynecomastia procedures. Their leadership stems from a specialized focus on outpatient care, inherently lower overhead costs compared to general hospitals, and efficient, streamlined patient intake protocols.

North America currently maintains the highest volume of gynecomastia procedures. This regional leadership is supported by a well-established and dense network of specialized plastic surgery practices, coupled with a high level of patient awareness regarding male aesthetic medicine and available corrective options.

The market is experiencing a definitive shift from traditional manual liposuction towards more advanced ultrasound-assisted (UAL) and power-assisted liposuction (PAL) systems, which offer greater precision and reduced trauma. Additionally, there's an evolution toward "skin-shrinking" technologies like radiofrequency and plasma-based energy to address post-liposuction skin laxity, alongside the development of "scarless" techniques like periareolar incisions.

Regulatory classification, distinguishing between purely cosmetic and medically necessary procedures, significantly influences insurance reimbursement and patient accessibility. High out-of-pocket costs, particularly where procedures are deemed cosmetic, lead to substantial pricing sensitivity, stimulating medical tourism and fostering competitive pricing models in emerging markets.

Strategic importance is placed on the development of "scarless" techniques, such as the periareolar incision or the "pull-through" method, which directly enhance patient uptake by minimizing visible surgical evidence. The market also emphasizes continuous technological refinement of liposuction systems and the adoption of energy-efficient, sustainable practices within specialized cosmetic centers.

Need data specifically for your business?Request Custom Research →

Trusted by the world's leading organizations

Weber Shandwick
veolia
Tri
tls
TeamViewer
GE Healthcare
Intel
Proctor and Gamble
ABB
Elkem
Defense Logistics Agency
Amazon